MSLN and ovarian cancer: Additionally, BBζ-Neo also effectively impeded the tumor growth and improved the survival of mice bearing xenograft tumors derived from MSLN-positive, Caov-3 human ovarian cancer cells (Supplementary Fig. 4e–g).